Functional skeletal muscle regeneration from differentiating embryonic stem cells.

Area of Science:

• Developmental biology
• Stem cell research
• Regenerative medicine

Background:

• Embryonic stem (ES) cells hold promise for studying skeletal muscle progenitors, but their use is limited by inefficient paraxial mesoderm formation and lack of specific markers.
• Current methods struggle with identifying and isolating reliable skeletal muscle precursors from in vitro differentiated ES cells.

Purpose of the Study:

• To enhance paraxial mesoderm formation and myogenic potential in differentiating ES cells.
• To develop a method for isolating skeletal muscle progenitors from ES cells for therapeutic applications.

Main Methods:

• Overexpression of the transcription factor Pax3 during embryoid body (EB) differentiation.
• Cell sorting using PDGF-alpha receptor (paraxial mesoderm marker) and Flk-1 (lateral plate mesoderm marker) exclusion.
• Transplantation of sorted cells into dystrophic mouse models.

Main Results:

• Pax3 expression improved paraxial mesoderm formation and myogenic potential in EBs.
• Initial Pax3-induced cells formed teratomas, indicating residual undifferentiated cells.
• Sorted cells (PDGF-alpha receptor+, Flk-1-) demonstrated significant muscle regeneration potential.
• Transplantation into dystrophic mice led to extensive myofiber engraftment and improved muscle function without teratomas.

Conclusions:

• Targeted manipulation of ES cell differentiation, including Pax3 expression and specific cell surface marker sorting, can yield functional skeletal muscle progenitors.
• This approach shows therapeutic potential for treating muscular dystrophy by enabling effective muscle regeneration.